
You can purchase shares of NOVARTIS AG BASEL AKT by Novartis AG (OTCPK:NVSEF) through any online brokerage.
There are no as such competitors for NOVARTIS AG BASEL AKT by Novartis AG.
There is no analysis for NOVARTIS AG BASEL AKT by Novartis AG to provide a consensus price target.
The stock price for NOVARTIS AG BASEL AKT by Novartis AG (OTCPK: NVSEF) is $160.97 last updated November 6, 2026 at 10:54 AM EST.
There are no upcoming dividends for NOVARTIS AG BASEL AKT by Novartis AG.
NOVARTIS AG BASEL AKT by Novartis AG does not have any upcoming earnings scheduled.
There is no upcoming split for NOVARTIS AG BASEL AKT by Novartis AG.
NOVARTIS AG BASEL AKT by Novartis AG is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises....